Genetek Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.35 Cr
as on 17-12-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 16.80 Cr
as on 17-12-2024
- Satisfied Charges ₹ 9.20 M
as on 17-12-2024
- Revenue 69.92%
(FY 2022)
- Profit 121.87%
(FY 2022)
- Ebitda 172.80%
(FY 2022)
- Net Worth 35.66%
(FY 2022)
- Total Assets 30.22%
(FY 2022)
About Genetek Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.35 Cr.
The company currently has active open charges totaling ₹16.80 Cr. The company has closed loans amounting to ₹9.20 M, as per Ministry of Corporate Affairs (MCA) records.
Surendra Hora, Aditya Mahendra, and Mahendra Kshirsagar serve as directors at the Company.
- CIN/LLPIN
U51101MH2012PTC228652
- Company No.
228652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Genetek Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Hora  | Director | 01-Feb-2015 | Current |
| Aditya Mahendra | Director | 18-Mar-2020 | Current |
| Mahendra Kshirsagar | Director | 22-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Genetek Lifesciences.
Genetek Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.92% increase. The company also saw a substantial improvement in profitability, with a 121.87% increase in profit. The company's net worth Soared by an impressive increase of 35.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genetek Lifesciences?
In 2021, Genetek Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shrinature Green Agrotech Private LimitedActive 4 years 5 months
Mahendra Kshirsagar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 27 Mar 2024 | ₹1.14 Cr | Open |
Sidbi Creation Date: 21 Jun 2021 | ₹1.95 Cr | Open |
Others Creation Date: 13 Aug 2012 | ₹13.71 Cr | Open |
How Many Employees Work at Genetek Lifesciences?
Genetek Lifesciences has a workforce of 60 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genetek Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetek Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
